Cargando…
Does tumour biology determine surgical success in the treatment of epithelial ovarian cancer? A systematic literature review
BACKGROUND: Ovarian cancer is the most lethal gynaecological cancer. Progression-free and overall survival is significantly related to surgical success and residual disease volume. It is unclear whether this survival advantage is due to an intrinsic biological element of the tumour cells which enabl...
Autores principales: | Borley, J, Wilhelm-Benartzi, C, Brown, R, Ghaem-Maghami, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461167/ https://www.ncbi.nlm.nih.gov/pubmed/22935582 http://dx.doi.org/10.1038/bjc.2012.376 |
Ejemplares similares
-
Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multicentre study
por: Phelps, David L, et al.
Publicado: (2017) -
Risk of Ovarian Cancer Relapse Score: A Prognostic Algorithm to Predict Relapse Following Treatment for Advanced Ovarian Cancer
por: Rizzuto, Ivana, et al.
Publicado: (2015) -
Is ovarian cancer surgery stuck in the dark ages?: a commentary piece reviewing surgical technologies
por: Phelps, David L., et al.
Publicado: (2020) -
NY-ESO-1 expression in DCIS: A new predictor of good prognosis
por: Coombes, R. Charles, et al.
Publicado: (2017) -
Synergy between liposomal zoledronic acid and γδ T-cells in the treatment of epithelial ovarian cancer
por: Pereira, Ana Catarina Parente, et al.
Publicado: (2013)